IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Experts predict ramped up enforcement, increased litigation targeting CBD products

FTC official outlines 15 criteria for studies that substantiate disease and treatment claims for CBD

This article is powered by Food Chemical News

From increased enforcement against CBD products making unsubstantiated claims to possible lawsuits targeting CBD product makers named in FDA latest salvo of 15 warning letters in November, experts predict new developments in 2020 that could help clean up the booming, but mostly unregulated CBD market.

Related Content


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts